[Genetic susceptibility of type 2 diabetes].
Hara
Kazuo
K
Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Kadowaki
Takashi
T
D052242:Adiponectin; D000682:Amyloid / Q000235:genetics; D000818:Animals; D002154:Calpain / Q000235:genetics; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D002890:Chromosomes, Human, Pair 20 / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000235:genetics*; D004777:Environment; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D015894:Genome, Human; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D058228:Islet Amyloid Polypeptide; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D011506:Proteins / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3 / Q000235:genetics; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics
D052242:Adiponectin; D000682:Amyloid; D036341:Intercellular Signaling Peptides and Proteins; D058228:Islet Amyloid Polypeptide; D011506:Proteins; D022702:Receptors, Adrenergic, beta-3; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D002154:Calpain; C415197:calpain 10